ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.44 USD
-7.11%
Market Closed
Updated:
Apr 26, 2024
ADC Therapeutics SA
Common Shares Outstanding
|
ADC Therapeutics SA
Common Shares Outstanding Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Common Shares Outstanding
$82.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Common Shares Outstanding
CHf99.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Common Shares Outstanding
$80m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Common Shares Outstanding
CHf12m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Common Shares Outstanding
CHf177.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Common Shares Outstanding
CHf36.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Common Shares Outstanding?
Common Shares Outstanding
82.3m
USD
82.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Common Shares Outstanding amounts to 82.3m USD.
What is ADC Therapeutics SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
1%
1%
Over the last year, the Common Shares Outstanding growth was 2%. The average annual Common Shares Outstanding growth rates for ADC Therapeutics SA have been 2% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
